Gary Woo

Gary Woo has extensive work experience in the biotechnology and healthcare industry. Gary is currently serving as the Senior Director of Digital Platforms at Landmark Bio since 2022. Prior to this, they worked at Amgen for a significant period, starting in 2011. At Amgen, they held various roles, including Director of Operations Digital Technology and Innovation, where they led the establishment of a digitally enabled manufacturing plant. Gary also served as a Senior Manager, overseeing Information Systems for biotech manufacturing sites and collaborating with different departments to optimize processes. Additionally, they worked as a Business Analyst, providing IS support to packaging and labeling operations.

Before joining Amgen, Gary worked at Quest Diagnostics as the Global Database Manager from 2008 to 2011. In this role, they managed the Clinical Trial Division's Database configuration and maintenance team, implementing process improvements for clinical trial data management.

In the earlier stages of their career, Gary worked at Amgen as a Project Manager/Specialist and a Research Associate, contributing to knowledge management strategy and conducting analytical method development and validation for lot release and stability purposes.

Gary began their career as a Senior Research Associate at One Lambda, Inc., where they focused on developing HLA-typing diagnostic kits and discovering new applications for monoclonal antibodies.

Overall, Gary Woo has a strong background in digital technology, operations management, information systems, packaging, labeling, clinical trial data management, and analytical method development in the biotechnology and healthcare sectors.

Gary Woo obtained a Bachelor of Science (BS) degree in Biology, General from the University of California, Los Angeles. In addition, they completed several relevant certifications, including "Introduction to Pharmacology" and "Pharmacology and Cardiovascular Health" from Study.com, as well as an "edX Verified Certificate for Making Biologic Medicines for Patients: The Principles of Biopharmaceutical Manufacturing" from edX.